Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Tiberghien

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1989
Recent studies on icosanoids and PAF-acether modulation of some central neurosecretions in the ratF Dray, K Gerozissis, V Fafeur, et al.
ACS Medicinal Chemistry Letters|November 25, 2016
Design and Synthesis of Tesirine, a Clinical Antibody-Drug Conjugate Pyrrolobenzodiazepine Dimer PayloadArnaud C Tiberghien, Jean-Noel Levy, Luke A Masterson, et al.
Bioorganic & Medicinal Chemistry Letters|February 12, 2017
Synthesis and in vitro evaluation of SG3227, a pyrrolobenzodiazepine dimer antibody-drug conjugate payload based on sibiromycinGary C Kemp, Arnaud C Tiberghien, Neki V Patel, et al.
Bioorganic & Medicinal Chemistry Letters|October 9, 2009
Synthesis of a novel C2/C2'-aryl-substituted pyrrolo[2,1-c][1,4]benzodiazepine dimer prodrug with improved water solubility and reduced DNA reaction ratePhilip W Howard, Zhizhi Chen, Stephen J Gregson, et al.
Antibodies (Basel, Switzerland)|September 25, 2019
Pyrrolobenzodiazepine Antibody-Drug Conjugates Designed for Stable Thiol ConjugationR James Christie, Arnaud C Tiberghien, Qun Du, et al.
Cancer Research|July 28, 2010
SG2285, a novel C2-aryl-substituted pyrrolobenzodiazepine dimer prodrug that cross-links DNA and exerts highly potent antitumor activityJohn A Hartley, Anzu Hamaguchi, Marissa Coffils, et al.
Molecular Cancer Therapeutics|February 1, 2023
Comparison of Pyrrolobenzodiazepine Dimer Bis-imine versus Mono-imine: DNA Interstrand Cross-linking, Cytotoxicity, Antibody-Drug Conjugate Efficacy and ToxicityArnaud C Tiberghien, Balakumar Vijayakrishnan, Arman Esfandiari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2018
SLC46A3 as a Potential Predictive Biomarker for Antibody-Drug Conjugates Bearing Noncleavable Linked Maytansinoid and Pyrrolobenzodiazepine WarheadsKrista Kinneer, John Meekin, Arnaud C Tiberghien, et al.
Journal of Medicinal Chemistry|March 12, 2010
Structure-activity relationships of monomeric C2-aryl pyrrolo[2,1-c][1,4]benzodiazepine (PBD) antitumor agentsDyeison Antonow, Maciej Kaliszczak, Gyoung-Dong Kang, et al.
Molecular Cancer Therapeutics|May 15, 2020
Preclinical Characterization of an Antibody-Drug Conjugate Targeting CS-1 and the Identification of Uncharacterized Populations of CS-1-Positive CellsRuoyan Chen, Saravanan Rajan, Michael G Overstreet, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1989
Recent studies on icosanoids and PAF-acether modulation of some central neurosecretions in the ratF Dray, K Gerozissis, V Fafeur, et al.
ACS Medicinal Chemistry Letters|November 25, 2016
Design and Synthesis of Tesirine, a Clinical Antibody-Drug Conjugate Pyrrolobenzodiazepine Dimer PayloadArnaud C Tiberghien, Jean-Noel Levy, Luke A Masterson, et al.
Bioorganic & Medicinal Chemistry Letters|February 12, 2017
Synthesis and in vitro evaluation of SG3227, a pyrrolobenzodiazepine dimer antibody-drug conjugate payload based on sibiromycinGary C Kemp, Arnaud C Tiberghien, Neki V Patel, et al.
Bioorganic & Medicinal Chemistry Letters|October 9, 2009
Synthesis of a novel C2/C2'-aryl-substituted pyrrolo[2,1-c][1,4]benzodiazepine dimer prodrug with improved water solubility and reduced DNA reaction ratePhilip W Howard, Zhizhi Chen, Stephen J Gregson, et al.
Antibodies (Basel, Switzerland)|September 25, 2019
Pyrrolobenzodiazepine Antibody-Drug Conjugates Designed for Stable Thiol ConjugationR James Christie, Arnaud C Tiberghien, Qun Du, et al.
Cancer Research|July 28, 2010
SG2285, a novel C2-aryl-substituted pyrrolobenzodiazepine dimer prodrug that cross-links DNA and exerts highly potent antitumor activityJohn A Hartley, Anzu Hamaguchi, Marissa Coffils, et al.
Molecular Cancer Therapeutics|February 1, 2023
Comparison of Pyrrolobenzodiazepine Dimer Bis-imine versus Mono-imine: DNA Interstrand Cross-linking, Cytotoxicity, Antibody-Drug Conjugate Efficacy and ToxicityArnaud C Tiberghien, Balakumar Vijayakrishnan, Arman Esfandiari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2018
SLC46A3 as a Potential Predictive Biomarker for Antibody-Drug Conjugates Bearing Noncleavable Linked Maytansinoid and Pyrrolobenzodiazepine WarheadsKrista Kinneer, John Meekin, Arnaud C Tiberghien, et al.
Journal of Medicinal Chemistry|March 12, 2010
Structure-activity relationships of monomeric C2-aryl pyrrolo[2,1-c][1,4]benzodiazepine (PBD) antitumor agentsDyeison Antonow, Maciej Kaliszczak, Gyoung-Dong Kang, et al.
Molecular Cancer Therapeutics|May 15, 2020
Preclinical Characterization of an Antibody-Drug Conjugate Targeting CS-1 and the Identification of Uncharacterized Populations of CS-1-Positive CellsRuoyan Chen, Saravanan Rajan, Michael G Overstreet, et al.
Pageof 3